Association between serum long-chain n-3 and n-6 polyunsaturated fatty acid profiles and glomerular filtration rate assessed by serum creatinine and cystatin C levels in Japanese community-dwellers

Journal of Epidemiology

Volumn 25, Issue 4, 2015, Pages 303-311

  Higashiyama, Aya ^a,b   Kubota, Yoshimi ^a,c   Marumo, Mikio ^a   Konishi, Masami ^d   Yamashita, Yoshiko ^d   Nishimura, Kunihiro ^b   Fukuda, Yoshihiro ^a   Okamura, Tomonori ^e   Wakabayashi, Ichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d Sasayama City Office   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

(EPA+DHA):AA; Epidemiology; Population based study

Indexed keywords

ARACHIDONIC ACID; CREATININE; CYSTATIN C; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; JAPAN; MALE; MIDDLE AGED; PHYSIOLOGY;

ADULT; ARACHIDONIC ACID; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; MALE; MIDDLE AGED;

EID: 84930241508     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20140093     Document Type: Article

References (32)

1. Lauretani F, Semba RD, Bandinelli S, Miller ER 3rd, Ruggiero C, Cherubini A, et al. Plasma polyunsaturated fatty acids and the decline of renal function. Clin Chem. 2008;54:475-81.
2. Iso H, Sato S, Folsom AR, Shimamoto T, Terao A, Munger RG, et al. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol. 1989;18:374-81.
3. Breslow JL. N-3 fatty acids and cardiovascular disease. Am J Clin Nutr. 2006;83(Suppl):1477S-82S.
4. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: The INTERMAP Study. J Hum Hypertens. 2003;17:623-30.
5. Shoji T, Kakiya R, Hayashi T, Tsujimoto Y, Sonoda M, Shima H, et al. Serum n-3 and n-6 polyunsaturated fatty acid profiles as an independent predictor of cardiovascular events in hemodialysis patients. Am J Kidney Dis. 2013;62:568-76.
6. Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, et al. Ratio of serum n-3 and n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J. 2012;76:423-9.
7. Kashiyama T, Ueda Y, Nemoto T, Wada M, Masumura Y, Matuso K, et al. Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acids ratio. Circ J. 2011;75:2432-8.
8. The Japanese Society of Nephrology. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi. 2012;54:1034-191.
9. Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, Greene T, et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int. 2011;79:471-4.
10. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652-60.
11. Ozawa A, Takayanagi K, Fujita T, Hirai A, Hamazaki T, Terano T, et al. Determination of long chain fatty acids in human total plasma lipids using gas chromatography. Bunseki Kagaku. 1982;31(2):87-91.
12. Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogeneous immunoassay for measuring serum cystatin C. Clin Biochem. 2004;37:27-35.
13. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S; Collaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61:197-203.
14. Nakamura Y, Ueshima H, Okamura T, Kadowaki T, Hayakawa T, Kita Y, et al. Association between fish consumption and allcause and cause-specific mortality in Japan: NIPPON DATA80, 1980-99. Am J Med. 2005;118:239-45.
15. Gopinath B, Harris DC, Flood VM, Burlutsky G, Mitchell P. Consumption of long-chain n-3 PUFA, alpha-linolenic acid and fish is associated with the prevalence of chronic kidney disease. Br J Nutr. 2011;105:1361-8.
16. Serikawa T, Miura SI, Okabe M, Hongo H, Tokutome M, Yoshikawa T, et al. The ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients. J Cardiol. 2014;63:35-40.
17. Hsu CC, Jhang HR, Chang WT, Lin CH, Shin SJ, Hwang SJ, et al. Association between dietary patterns and kidney function indicators in type 2 diabetes. Clin Nutr. 2014;33:98-105.
18. Miller ER III, Juraschek SP, Appel LJ, Madala M, Anderson CA, Bleys J, et al. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am J Clin Nutr. 2009;89:1937-45.
19. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. N Engl J Med. 1994;331:1194-9.
20. Grande JP, Walker HJ, Holub BJ, Warner GM, Keller DM, Haugen JD, et al. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int. 2000;57: 1027-40.
21. Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factorbeta to prevent human essential hypertension. Eur J Clin Nutr. 2004;58:195-203.
22. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J Am Soc Nephrol. 2003;14:389-96.
23. de Jonge HW, Dekkers DH, Lamers JM. Polyunsaturated fatty acids and signaling via phospholipase C-beta and A2 in myocardium. Mol Cell Biochem. 1996;157:199-210.
24. Minuz P, Jiang H, Fava C, Turolo L, Tacconelli S, Ricci M, et al. Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. Hypertension. 2008;51:1379-85.
25. Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, et al. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids. J Biol Chem. 2010;285:32720-33.
26. Cicero AF, Derosa G, Di Gregori V, Bove M, Gaddi AV, Borghi C. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglycemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens. 2010;32: 137-44.
27. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376:540-50.
28. Manger MS, Strand E, Ebbing M, Seifert R, Refsum H, Nordrehaug JE, et al. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. Am J Clin Nutr. 2010;92: 244-51.
29. Nurk E, Drevon CA, Refsum H, Solvoll K, Vollset SE, Nygård O, et al. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. Am J Clin Nutr. 2007;86:1470-8.
30. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275-84.
31. Statistics and Information Department, Minister Secretariat, Ministry of Health, Labor and Welfare. Vital statistics in Japan, trends up to 2012 [homepage on the Internet] [cited 2014 May 1]. Available from: http://www.mhlw.go.jp/toukei/list/dl/81-1a2.pdf.
32. Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, et al. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: The Hisayama Study. Nephrol Dial Transplant. 2010;25:2557-64.